Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerBilling CodesInjection and Intravenous Infusion Chemotherapy and Other Highly Complex Drug or Highly Complex Biologic Agent AdministrationCPT cpt-96409-intravenous-push-chemotherapy-initial-drug
    Ask Trek AI about this page

    CPT 96409: Intravenous Push Chemotherapy, Single/Initial Drug

    Medicare pays $109 on average nationally for this procedure.

    CPT code 96409 describes the administration of chemotherapy by intravenous push for a single or initial drug; this is a brief chemotherapy administration service typically performed by an oncology clinician in outpatient infusion centers or clinic settings and is classified as an intravenous (IV) push medication administration service rather than a continuous infusion or infusion pump procedure.

    For related coverage guidance, see recent payer policy updates: Bendamustine Products Coverage Criteria, T-Cell Lymphoma Agents: Beleodaq, Istodax, Lymphir, Poteligeo, and Romidepsin, Brentuximab Vedotin (Adcetris®) Coverage Criteria.

    Customize your policy alerts

    Sign up for cpt 96409 policy alerts

    Get alerted when payer policies referencing 96409 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Table of contents

    Progress1 / 7

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical & Coding Specifications

    Clinical Context

    A 62-year-old female with metastatic breast cancer presents to the infusion clinic for administration of a single-agent chemotherapy dose. The oncology advanced practice provider reviews vital signs and labs, confirms chemotherapy orders, verifies informed consent, and performs line access assessment. The provider administers the chemotherapy drug via an intravenous push (bolus) through a peripheral IV or implanted port, observes the patient for immediate adverse reactions for the required monitoring period, documents drug name, dose, route, site, lot number, and start/stop times, and communicates aftercare instructions. Typical workflow includes order verification by pharmacy, bedside medication preparation, clinician verification of patient identity and pre-medications, IV push administration using aseptic technique, post‑administration observation, and documentation in the medical record. Typical sites of service are hospital outpatient infusion centers, physician offices, ambulatory infusion suites, and oncology clinics.

    Related CPT Codes

    CPT CodeDescriptionRelationship to This Procedure
    36415Collection of venous blood by venipuncturePerformed prior to 96409 for necessary labs (CBC, chemistries) to assess chemotherapy eligibility.
    36561Insertion of peripheral IV catheter; radiopaque catheterUsed when a new peripheral IV is placed for administration of the IV push agent if no existing access is available.
    96372Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscularMay be performed for pre‑medications (e.g., antiemetic or antihistamine) given on the same day as 96409 but via a different route.
    96413Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drugUsed for short IV infusions of chemotherapy; selected instead of 96409 when drug is given as an infusion rather than an IV push.
    96365Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hourUsed when an infusion rather than an IV push is clinically appropriate during the same encounter.

    Related Modifiers

    9 rows

    ModifierDescriptionWhen to Use
    25CPT modifier 25 indicates that on the same day as another procedure or service, the same physician or other qualified health care professional provided a significant, separately identifiable…- When to apply: Use modifier 25 only on an E/M code to indicate the same provider delivered a significant, separately identifiable E/M service on the same day as another procedure or service — i.e.,…
    59Modifier 59 indicates a distinct procedural service when two procedures that are not normally billed together are clinically and procedurally separate. The CPT definition (as reiterated by CMS)…- Use modifier -59 to report a distinct procedural service when documentation supports that the procedure reported is not normally billed together with another service on the same day because of a…
    62Modifier 62 indicates that two surgeons function as co‑surgeons, each performing distinct parts of the same primary surgical procedure. It is appended to the primary procedure code (and any…- Use modifier -62 when two surgeons act as co‑surgeons (both primary surgeons) on a single definitive primary procedure, each performing distinct parts of the same surgical procedure (append -62 to…
    76Modifier -76, Repeat Procedure or Service by Same Physician or Other Qualified Health Care Professional, is appended when the same provider performs an identical, medically necessary procedure or…- Use modifier -76 when the same physician or other qualified health care professional performs an identical procedure or service a second (or subsequent) time on the same date of service and the…
    78CPT modifier -78 indicates an unplanned, related return to the operating or procedure room by the same provider during the global postoperative period. It is appended when treatment for a…- Use modifier -78 when an unplanned, related complication during the original procedure’s global postoperative period requires the patient to return to a formal operating or procedure room and the…
    80CPT® Modifier 80 (Assistant Surgeon) is appended to a surgical CPT code when a physician (MD or DO) provides full, continuous assistance throughout the operative procedure. It is intended only for…- Use CPT Modifier -80 when a physician (MD or DO) serves as an assistant surgeon and provides full, continuous assistance throughout the entire operative procedure; append -80 to the surgical CPT…
    51Modifier –51 (Multiple Procedures) is used when the same provider performs multiple procedures in the same session to identify secondary, non‑exempt procedures and indicate payment reduction logic…- Use modifier -51 when the same provider performs multiple distinct procedures during the same patient encounter: report the highest‑valued procedure first (no modifier) and append -51 to…
    52Modifier ‑52 (Reduced Services) indicates that a service or procedure was partially reduced or omitted at the provider’s discretion, allowing reporting of the basic procedure number with a qualifier…- Use modifier -52 when a physician or qualified health professional electively reduces or omits part of a procedure or service (for example, performing fewer required views or omitting a portion of…
    53Modifier 53 (Discontinued Procedure) signals that a surgical or diagnostic service was begun by the physician but terminated because of extenuating circumstances that threatened the patient’s…- Use modifier -53 when a physician/qualified healthcare professional has started a surgical or diagnostic procedure (e.g., anesthesia administered, incision or scope insertion) and then discontinues…

    Related Provider Taxonomies

    8 rows

    Taxonomy Code
    224900000X
    261Q00000X
    332S00000X
    207SG0201X
    246ZE0600X
    207XX0801X
    171400000X
    1223D0004X

    Related ICD-10-CM Codes

    28 rows

    ICD-10-CM CodeDescription
    C15.9Malignant neoplasm of esophagus, unspecified
    C16.9Malignant neoplasm of stomach, unspecified
    C18.9Malignant neoplasm of colon, unspecified
    C20Malignant neoplasm of rectum
    C22.0Liver cell carcinoma
    C25.9Malignant neoplasm of pancreas, unspecified
    C34.90Malignant neoplasm of unspecified part of unspecified bronchus or lung
    C43.9Malignant melanoma of skin, unspecified
    C45.9Mesothelioma, unspecified
    C50.912Malignant neoplasm of unspecified site of left female breast

    Showing 1–10 of 28

    Related Payer Policy Updates

    Specialty: Hematology/Oncology1 / 3

    10 rows

    PolicyPayerEffective Date
    Bendamustine Products Coverage Criteriablue cross blue shield - tennessee2027-01-30
    T-Cell Lymphoma Agents: Beleodaq, Istodax, Lymphir, Poteligeo, and RomidepsinMass General Brigham Health Plan2027-01-04
    Brentuximab Vedotin (Adcetris®) Coverage Criteriablue cross blue shield - tennessee2026-12-31
    Pemetrexed Coverageblue cross blue shield - tennessee2026-12-31
    Tumor Treatment Fields - Medical PolicyHealth-New-England2026-12-01
    Extracorporeal PhotopheresisCigna2026-11-15
    VonvendiCigna2026-11-15
    Hematology - AphexdaCigna2026-11-15
    Extracorporeal PhotopheresisCigna2026-11-15
    Yartemlea (narsoplimab-wuug) Coverage for TA-TMANeighborhood Health Plan of Rhode Island2026-11-01

    Related Codes

    CPT-96401-SUBCUTANEOUS-INTRAMUSCULAR-CHEMOTHERAPY-ADMINISTRATION

    CPT 96401: Subcutaneous or Intramuscular Nonhormonal Chemotherapy

    CPT-96402-SUBCUTANEOUS-INTRAMUSCULAR-HORMONAL-ANTINEOPLASTIC-ADMINISTRATION

    CPT 96402: Subcutaneous/Intramuscular Hormonal Anti‑Neoplastic Administration

    CPT-96405-INTRALESIONAL-CHEMOTHERAPY-ONE-TO-SEVEN-LESIONS

    CPT 96405: Intralesional Chemotherapy, 1–7 Lesions

    CPT-96406-INTRALESIONAL-CHEMOTHERAPY-MORE-THAN-7-LESIONS

    CPT 96406: Intralesional Chemotherapy for >7 Lesions

    CPT-96411-ADD-ON-INTRAVENOUS-PUSH-CHEMOTHERAPY-DRUG

    CPT 96411: Add-On IV Push for Additional Chemotherapy Drug

    CPT-96413-INTRAVENOUS-CHEMOTHERAPY-INFUSION-INITIAL-HOUR

    CPT 96413: Intravenous Chemotherapy Infusion, Initial Hour

    CPT-96415-ADDITIONAL-HOUR-CHEMOTHERAPY-INTRAVENOUS-INFUSION

    CPT 96415: Continued Intravenous Chemotherapy Infusion, Per Additional Hour

    CPT-96416-CHEMOTHERAPY-INITIATION-PORTABLE-IMPLANTABLE-PUMP

    CPT 96416: Initiation of Intravenous Chemotherapy via Pump

    CPT-96417-ADD-ON-IV-CHEMOTHERAPY-INFUSION-DIFFERENT-AGENT

    CPT 96417: Continued Intravenous Chemotherapy Administration

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.